drugset / Trial / NCT02056171

Efficacy of Quetiapine for Pediatric Delirium

NCT02056171

Phase 1/2 Terminated 6 enrolled Weill Medical College of Cornell University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study is designed to assess the safety and efficacy of quetiapine as treatment for pediatric delirium.

Timeline

Start
2015-03
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule

Indications